EU Safety Gate (RAPEX) · France · 2025-08-29 · Serious risk
🌐Machine-translated with AI — the facts come from the issuing authority’s own notice (linked on this page); this language version was translated automatically by an AI model and is not reviewed. The original-language notice is authoritative. How we use AI →
Reported risk: L'étiquetage du produit ne comporte pas les informations de danger et d'avertissement appropriées et l'utilisateur n'est pas correctement informé que ce produit contient du dichlorométhane. Le dichlorométhane affecte le système nerveux central, peut altérer le neurodéveloppement et le comportement de l'enfant à naître et peut provoquer un cancer par inhalation. Le produit n'est pas conforme au règlement sur la classification, l'étiquetage et l'emballage des substances et des mélanges (CLP).
Action taken by the authority
Type of economic operator taking notified measure
Distributor
Category of measure
Recall of the product from end users
Date of entry into force
05/09/2025
Machine translation. This page was translated automatically from the English record we hold of the issuing authority’s notice. The English original is shown below and the authority’s own notice is linked above — both take precedence over this translation.
Product Name (original English): Polimero Liquido para faros
Risk Description (original English): The labelling on the product does not include the appropriate hazard and warning information and the user is not properly informed that this product contains dichloromethane. Dichloromethane affects the central nervous system, can impair the neuro-development and behaviour of the unborn child and might cause cancer when inhaled.
Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.
ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.